What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially report HCA Healthcare's issuance and sale of $500,000,000 in aggregate principal amount of its 6 3/4% Notes due July 15, 2013, and to file the related documentation as exhibits.

What are the key financial terms of the notes issued?

HCA Healthcare issued 6 3/4% Notes with a principal amount of $500,000,000, maturing on July 15, 2013. The issuance was structured into two tranches: one for $400,000,000 and another for $100,000,000.

What exhibits are included with this filing?

The filing includes the Underwriting Agreement (Terms) dated July 23, 2003, the specific note agreement for the $400,000,000 principal amount of 6 3/4% Notes due July 15, 2013 (Exhibit 4.1), and the specific note agreement for the $100,000,000 principal amount of 6 3/4% Notes due July 15, 2013 (Exhibit 4.2).

How does this debt issuance affect HCA Healthcare's financial position?

This debt issuance increases HCA Healthcare's total debt and financial leverage. Investors should consider the implications of the $500 million in new debt on the company's debt-to-equity ratio, interest coverage ratios, and its ability to meet future debt obligations, including the semi-annual interest payments at a 6 3/4% rate.

HCA 8-K SEC Disclosure — Jul 29, 2003

Summary

HCA Healthcare, Inc. (HCA) filed a Form 8-K on July 28, 2003, to report on events occurring on July 22, 2003. The primary focus of this filing is the issuance and sale of an aggregate of $500,000,000 principal amount of its 6 3/4% Notes due July 15, 2013. This offering represents a significant financing event for the company, aimed at raising capital for its operations or strategic initiatives. The filing includes key exhibits related to this debt issuance, specifically the Underwriting Agreement (Terms) dated July 23, 2003, and the actual Note agreements for the $400,000,000 and $100,000,000 portions of the total debt. Investors should note the terms of these notes, including the interest rate and maturity date, as they impact the company's financial leverage and future interest payment obligations.

Key Highlights

1HCA Healthcare announced the issuance and sale of $500 million in 6 3/4% Notes due July 15, 2013.
2The filing includes the Underwriting Agreement (Terms) dated July 23, 2003.
3Specific note agreements for $400 million and $100 million, both maturing on July 15, 2013, are filed.
4This is a significant debt financing event for HCA Healthcare.
5The filing was made on July 28, 2003, reporting on events from July 22, 2003.

HCA Healthcare, Inc. 8-K Report (Jul 29, 2003)

Summary

Key Highlights

Frequently Asked Questions